Autoimmune diseases induced by TNF-targeted therapies

M Ramos-Casals, P Brito-Zerón, MJ Soto… - Best practice & research …, 2008 - Elsevier
Anti-TNF agents are increasingly being used for a rapidly expanding number of rheumatic
and systemic autoimmune diseases. As a result of this use, and of the longer follow-up …

Autoimmune diseases induced by biological agents: a double-edged sword?

M Ramos-Casals, C Diaz-Lagares, MJ Cuadrado… - Autoimmunity …, 2010 - Elsevier
Biological agents are increasingly used for a rapidly-expanding number of rheumatic and
systemic autoimmune diseases, with a growing number of reports of the paradoxical …

Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature

M Ramos-Casals, MJ Cuadrado, P Alba, G Sanna… - Medicine, 2008 - journals.lww.com
Few studies have evaluated the impact of viral infections on the daily management of
patients with systemic lupus erythematosus (SLE). We analyzed the etiology and clinical …

[HTML][HTML] The management of thrombosis in the antiphospholipid-antibody syndrome

MA Khamashta, MJ Cuadrado, F Mujic… - … England Journal of …, 1995 - Mass Medical Soc
Background The antiphospholipid-antibody syndrome is a thrombophilic disorder in which
venous or arterial thrombosis, or both, may occur in patients with antiphospholipid …

The 2023 ACR/EULAR antiphospholipid syndrome classification criteria

M Barbhaiya, S Zuily, R Naden, A Hendry… - Arthritis & …, 2023 - Wiley Online Library
Objective To develop new antiphospholipid syndrome (APS) classification criteria with high
specificity for use in observational studies and trials, jointly supported by the American …

EULAR recommendations for the management of antiphospholipid syndrome in adults

MG Tektonidou, L Andreoli, M Limper… - Annals of the …, 2019 - ard.bmj.com
The objective was to develop evidence-based recommendations for the management of
antiphospholipid syndrome (APS) in adults. Based on evidence from a systematic literature …

Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases

M Ramos-Casals, P Brito-Zerón, S Muñoz, N Soria… - Medicine, 2007 - journals.lww.com
Tumor necrosis factor (TNF)-targeted therapies are increasingly used for a rapidly
expanding number of rheumatic and autoimmune diseases. With this use and longer follow …

Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF‐κB …

C López‐Pedrera, P Buendía… - … : Official Journal of …, 2006 - Wiley Online Library
Objective Antiphospholipid syndrome (APS) is characterized by thrombosis and the
presence of antiphospholipid antibodies (aPL). In patients with primary APS, expression of …

Thrombosis in primary antiphospholipid syndrome. A pivotal role for monocyte tissue factor expression

MJ Cuadrado, C López‐Pedrera… - … : Official Journal of …, 1997 - Wiley Online Library
Objective. The antiphospholipid syndrome (APS) is a disorder of recurrent thrombosis,
pregnancy loss, and thrombocytopenia associated with the production of anticardiolipin …

The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review

S Sciascia, G Sanna, MA Khamashta… - Annals of the …, 2015 - ard.bmj.com
Background Around 10% of all thrombotic cerebrovascular events (CVE) occur in young
population and in a large proportion of those the trigger remains undetermined …